A detailed history of Level Four Advisory Services, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Level Four Advisory Services, LLC holds 10,422 shares of BIIB stock, worth $1.82 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
10,422
Previous 7,212 44.51%
Holding current value
$1.82 Million
Previous $1.56 Million 55.37%
% of portfolio
0.11%
Previous 0.08%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$190.52 - $236.72 $611,569 - $759,871
3,210 Added 44.51%
10,422 $2.42 Million
Q1 2024

May 13, 2024

BUY
$212.02 - $267.71 $2,756 - $3,480
13 Added 0.18%
7,212 $1.56 Million
Q4 2023

Feb 08, 2024

SELL
$222.59 - $267.94 $35,169 - $42,334
-158 Reduced 2.15%
7,199 $1.86 Million
Q3 2023

Nov 13, 2023

BUY
$253.3 - $285.89 $68,644 - $77,476
271 Added 3.82%
7,357 $1.89 Million
Q2 2023

Jul 10, 2023

BUY
$275.25 - $318.06 $9,633 - $11,132
35 Added 0.5%
7,086 $2.02 Million
Q1 2023

Jun 05, 2023

SELL
$256.56 - $292.34 $8,723 - $9,939
-34 Reduced 0.48%
7,051 $1.96 Million
Q4 2022

Feb 13, 2023

SELL
$252.44 - $306.72 $284,247 - $345,366
-1,126 Reduced 13.71%
7,085 $1.96 Million
Q3 2022

Nov 07, 2022

SELL
$194.69 - $268.46 $1.64 Million - $2.26 Million
-8,427 Reduced 50.65%
8,211 $2.19 Million
Q2 2022

Aug 08, 2022

BUY
$187.54 - $223.02 $134,841 - $160,351
719 Added 4.52%
16,638 $3.39 Million
Q1 2022

May 10, 2022

BUY
$193.77 - $244.14 $757,059 - $953,854
3,907 Added 32.53%
15,919 $3.35 Million
Q4 2021

Feb 11, 2022

BUY
$223.92 - $287.77 $532,257 - $684,029
2,377 Added 24.67%
12,012 $2.88 Million
Q3 2021

Oct 12, 2021

BUY
$282.99 - $369.05 $2,829 - $3,690
10 Added 0.1%
9,635 $2.73 Million
Q2 2021

Aug 09, 2021

BUY
$259.0 - $414.71 $159,026 - $254,631
614 Added 6.81%
9,625 $3.33 Million
Q1 2021

May 10, 2021

BUY
$242.95 - $284.63 $940,945 - $1.1 Million
3,873 Added 75.38%
9,011 $2.52 Million
Q4 2020

Feb 10, 2021

SELL
$236.26 - $355.63 $325,802 - $490,413
-1,379 Reduced 21.16%
5,138 $1.26 Million
Q3 2020

Nov 02, 2020

BUY
$264.77 - $305.71 $209,433 - $241,816
791 Added 13.81%
6,517 $1.85 Million
Q2 2020

Aug 17, 2020

BUY
$258.66 - $342.55 $1.48 Million - $1.96 Million
5,726 New
5,726 $1.54 Million
Q2 2020

Jul 27, 2020

SELL
$258.66 - $342.55 $1.63 Million - $2.16 Million
-6,316 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$268.85 - $341.04 $136,306 - $172,907
507 Added 8.73%
6,316 $1.99 Million
Q4 2019

Feb 13, 2020

BUY
$220.06 - $304.07 $203,555 - $281,264
925 Added 18.94%
5,809 $8.67 Million
Q3 2019

Nov 12, 2019

BUY
$217.44 - $243.88 $98,717 - $110,721
454 Added 10.25%
4,884 $1.14 Million
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $30,262 - $33,357
138 Added 3.22%
4,430 $1.04 Million
Q1 2019

May 15, 2019

BUY
$216.71 - $338.96 $60,245 - $94,230
278 Added 6.93%
4,292 $1.01 Million
Q4 2018

Feb 08, 2019

BUY
$278.5 - $352.75 $251,485 - $318,533
903 Added 29.03%
4,014 $1.21 Million
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $913,109 - $1.19 Million
3,111 New
3,111 $1.1 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Level Four Advisory Services, LLC Portfolio

Follow Level Four Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.